Critical Glaucoma Insights! Our latest event with Dr. Mitch Ibach covered essential strategies for diagnosing and managing glaucoma over the long term. Here’s a detailed recap of what you need to know!
Key Takeaways:
Long-Term Risk of Glaucoma: Patients with ocular hypertension have a 45% chance of progressing to glaucoma over 20 years, with medication only slightly reducing that risk.
Diagnostic Indicators: Dr. Ibach highlighted OCT changes that matter, like inter-eye macular asymmetry of 5 microns, intra-eye asymmetry of 9 microns, and low RNFL thickness, all red flags for glaucoma progression. Low corneal hysteresis (<9.5) is a particularly strong risk factor for progression, indicating that the optic nerve has poor shock-absorbing properties.
Prostaglandin First-Line Treatment: Prostaglandins remain first-line due to their efficacy, ease of once-daily dosing, and minimal systemic side effects. Reducing IOP by even 1 mmHg lowers the risk of progression by 10-20%.
Family History: A first-degree family history increases glaucoma risk 9-fold, underscoring the importance of proactive monitoring for these patients.
Dr. Ibach emphasized the medical-minded optometrist’s role in early diagnosis, lowering IOP, and monitoring for long-term progression to preserve vision.
🔗 Explore the full insights and download session handouts at WooU.org under ‘Past Events’.